SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Robert Langreth
Tech
Merck snags Chinese obesity drug in nearly $2 billion deal
By
Robert Langreth
and
Bloomberg
Health
Ozempic linked to rare cases of vision loss in Harvard study
By
Robert Langreth
and
Bloomberg
Health
Lilly wins FDA approval for new drug to slow Alzheimer’s
By
Madison Muller
,
Robert Langreth
, and others
Politics
‘Outrageous’: Bernie Sanders has Ozempic demands after study says it costs just $5 per month to manufacture
By
Madison Muller
,
Robert Langreth
, and others
Health
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
By
Madison Muller
,
Robert Langreth
, and others
Health
Moderna’s updated COVID vaccine helps fight against a new strain, study shows, and may be approved for use as soon as Friday
By
Robert Langreth
and
Bloomberg
Health
Moderna’s Omicron vaccine produces antibodies against new variants, new trial shows
By
Robert Langreth
and
Bloomberg
Health
Moderna says its Omicron-specific vaccine boosts antibodies in new trial
By
Robert Langreth
and
Bloomberg
Health
New prescription drug prices soared to $180,000 a year on 20% annual inflation in 2021, study finds
By
Robert Langreth
and
Bloomberg
Health
Pfizer says a third vaccine dose boosts antibodies against Omicron in kids 5 to 11
By
Robert Langreth
and
Bloomberg
Health
Almost all teens needing ICU care for COVID are unvaccinated
By
Robert Langreth
and
Bloomberg
Health
FDA set to authorize Pfizer and Merck COVID pills this week
By
Josh Wingrove
,
Jennifer Jacobs
, and others
Health
Pfizer: COVID vaccine is 91% effective in kids ages 5 to 11
By
Robert Langreth
and
Bloomberg
Health
Pfizer submits request to authorize COVID vaccine for kids to FDA
By
Robert Langreth
,
Catherine Larkin
, and others
Health
Two recent studies help explain breakthrough infections in those with two COVID-19 vaccine doses
By
Alisa Odenheimer
,
Robert Langreth
, and others